The Danish drugmaker sued Hims in February over compounded versions of the Wegovy weight-loss pill that Hims launched and ...

By Stine Jacobsen and Maggie Fick COPENHAGEN, March 9 (Reuters) - Novo Nordisk has agreed to sell its blockbuster Wegovy and Ozempic drugs through U.S. telehealth company Hims & Hers' platform, the ...

A recent small study has found that people may be able to maintain their weight loss with fewer GLP-1 injections, but this ...

A few months into GLP-1 treatment, many patients encounter an unexpected and distressing side effect: significant hair loss.

Alternatives to Ozempic for Weight Loss This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Ozempic is an ...

Eye strokes’ that reduce blood flow to optic nerve likely to be side-effect of active ingredient semaglutide, says author ...

Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in ...

Weight loss jab ‘may carry higher risk of sudden sight loss’ as new warning issued - Wegovy is approved on the NHS to help people lose weight in higher doses ...

Share on Pinterest Researchers believe that high doses of semaglutide may reduce blood flow to the optic nerve, which could lead to eye stroke. Maria Korneeva/Getty Images A new study has found that ...

Scammers are exploiting the Ozempic craze with fraudulent offers and undisclosed charges.

Citi stays 'neutral' on Novo Nordisk as crowded obesity market threatens to erode its competitive edge Novo Nordisk (NYSE:NVO), the Danish pharma giant behind the Ozempic and Wegovy weight-loss drugs, ...

Popular weight-loss drugs such as Ozempic, Wegovy, and Mounjaro may do more than help people shed pounds. New research suggests these GLP-1 medications could also help protect the heart after a heart ...